Effect Of Virtual Reality On Pulmonary Function And Anxiety Levels In Asthmatic Patients (NCT07141212) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Effect Of Virtual Reality On Pulmonary Function And Anxiety Levels In Asthmatic Patients
Egypt40 participantsStarted 2025-08-30
Plain-language summary
The Purpose of the Study This study will be conducted to determine the effect of virtual reality on pulmonary function and anxiety levels in moderate to severe asthmatic patients.
Who can participate
Age range
30 Years – 40 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Both sexes would be previously diagnosed as bronchial asthma with a cut-off score FEV1: Between 60% and 80% of predicted value or less than 60% of predicted value and FEV1/FVC ratio: May be significantly reduced from normal value 0.75-0.80.
* The age of the patients will be ranged between 30 and 40 years old.
* Asthma Control Test(ACT) will be less than 16 can be successfully used to identify those who will be uncontrolled asthma.
* All patients will be assessed by Hospital Anxiety and Depression Scale (HADS) ;A cut-off score of 11-15 a moderate depression/anxiety level.
* Patients who are conscious and cooperative.
* Patients who are able to understand and follow instruction.
Exclusion Criteria:
* Previous participation in any pulmonary rehabilitation program.
* Cardiovascular instabilities such as: Uncontrolled hypertension, Uncontrolled arrhythmia and Recent ischemic event.
* Mental disorders preventing protocol implementation.
* Other chronic respiratory diseases.
* Pregnant women.
* New or current smoker.
* Respiratory tract infection.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Control pause breathing test
Timeframe: 8 weeks
2
Asthma control test
Timeframe: 8 weeks
3
Forced Expiratory Volume in one second (FEV1)
Timeframe: 8 weeks
4
Forced vital capacity (FVC)
Timeframe: 8 weeks
5
FEV1/FVC ratio
Timeframe: 8 weeks
6
Peak expiratory flow (% predicted)
Timeframe: 8 weeks
7
Anxiety level by Hospital Anxiety and Depression Scale (HADS)